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Objectives: There is an increasing movement to collect and report patient reported outcome measures
(PROM’s) following total hip replacement (THR). In the UK, the procedure speciﬁc PROM of choice is the
Oxford Hip Score (OHS). It is currently unclear how to use this information to determine outcome
following surgery. The aim of this study was to deﬁne a threshold for the OHS that is correlated with
patient satisfaction.
Design: Prospective cohort study.
Setting: A district general hospital (St. Helier Hospital, Carshalton, UK).
Participants: 799 patients receiving THR from 1995 to 2004.
Main outcome measures: At 12 and 24 months after surgery patients were asked if they were satisﬁed
with surgery and completed the OHS. Receiver operating characteristic (ROC) analyses were used to
identify thresholds of follow-up OHS, which best discriminated patient satisfaction. Analyses were
stratiﬁed by age, sex, body mass index (BMI), baseline OHS and patient expectations.
Results: 91.9% of patients were satisﬁed with THR at 12 months (92.8% at 24 months). Using the ROC
technique, the OHS at 12 months associated with patient satisfaction was 38 and at 24 months 33. The
OHS at 24 months associated with satisfaction was higher in those with highest tertile of baseline OHS
(30, 33, 43 respectively), and lowest tertile of BMI.
Conclusions: We have identiﬁed a value of the OHS that predicts patient satisfaction 12e24 months
following THR within a standard clinical setting. However, this threshold is markedly inﬂuenced by pre-
operative OHS and should be stratiﬁed accordingly.
 2010 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
Every year in the UK, over 70,000 total hip replacements (THR’s)
are performed1, with 500,000 per year in the US2, predominantly
for osteoarthritis3. The number is set to increase over the next few
years due to an increasing elderly population. The operation is
thought to have an excellent outcome, with success rates of over
90% reported at 10 years4. However, success in these studies is
deﬁned by survival of the prosthesis, whereas there is an increasing
movement to assess outcome after surgery using patient reportedNigel K. Arden, Oxford NIHR
y of Oxford, Windmill Road,
-764027; Fax: 44-(0)-2380-
.
Elsevier Ltd on behalf of Osteoartoutcome measures (PROM’s), which may yield lower success rates
than the currently quoted ﬁgures using prosthesis survival.
Themost commonly used outcome following THR in the UK is the
Oxford Hip Score (OHS). It was introduced in 1996 as a PROM
predominantly for use in clinical trials5. It is joint speciﬁc and has
been extensively assessed for reliability and validity6,7. It is widely
used and has been adopted as the outcome of choice for both the
National Joint Registry (NJR) and the UK Government PROM initia-
tive. The OHS was originally designed for use in clinical studies to
measure population based changes rather than individual changes in
outcome. One of the most important patient related outcomes is
satisfaction with surgery, where an appreciable minority of patients
have been shown to be unsatisﬁed with the outcome of their THR
surgery8.
The aim of this study was examine whether it is possible to
deﬁne a post-operative OHS threshold that discriminated patient
satisfaction with the operation.hritis Research Society International.
Fig. 1. Venn diagram showing the number of participants involved in the study
(799 subjects recruited at baseline).
N.K. Arden et al. / Osteoarthritis and Cartilage 19 (2011) 155e162156Methods
In 1999 an outcome programmewas established for all patients
undergoing THR at St. Helier Hospital, Carshalton. This is a busy
district general hospital serving a local population of about
320,000 in the London boroughs of Sutton and Merton. The pro-
gramme was designed to monitor the progress of patients whose
operations were undertaken since the beginning of 1995. Whilst
the study was formally active from 1995 to 2004, data has been
collected outside of this range due to backtracking of patients into
the database (pre-1995) and extraction of St. Helier patients from
a large merged south west cohort (post 2004). The range of
operation dates are 1986e2007, with median interquartile range
(IQR) of 2002 (2000, 2004); 87% of operations occurred between
1995 and 2004.
All patients admitted for a THR completed a pre-operative ques-
tionnaire including anOHSandwere subsequently sent annual postal
questionnaires to assess outcome and satisfaction. Those patients
that received an elective THR were recruited into the study; emer-
gency THR patients were excluded. Subjects with previous hip frac-
tures were also excluded. The review programme was run by
members of the orthopaedic research and outcome unit and was
independent of the patients continuing clinical care. The hip
replacement surgery was performed by multiple consultant ortho-
paedic surgeons and their supervised trainees. The operating surgeon
was not directly involved in the collection of data for the review
programme. Pre-operative informationwas collected on patient age,
gender, height and weight [from which body mass index (BMI) was
calculated]. Patients were also asked the following questions
regarding their expectations of surgery: (1) “How painful do you
expect your hip to be when you are fully recovered from this surgery? -
Not at all painful, slightly painful, very painful”, (2) “How limited do you
expect to be in your usual activities, when you are fully recovered from
this surgery? - Not limited at all, slightly limited, moderately limited,
greatly limited”. They were also asked “How long did it take before you
recovered fully from your operation?”.
At the 12 and 24-month follow-up visits, in addition to the
OHS, subjects were asked “Are you satisﬁed with the result of your
hip replacement?” - the patients answered Yes or No to each
question. The OHS consists of 12 questions asking patients to
describe their hip pain and function during the past 4 weeks5.
Each question is on a Likert scale taking values from 0 to 4. An
overall score is created by summing the responses to each of the
12 questions. The total score can range from 0 to 48, where 0 is the
worst possible score indicating severe hip symptoms and 48 is
the best score suggesting excellent joint function. The change in
OHS was the follow-up score minus the baseline score, and
percentage of potential improvement (PoPI) deﬁned as the
percentage of the maximum potential beneﬁt that the patient
could achieve (follow-up score minus baseline score, divided by
48 minus baseline score, multiplied by 100).
Statistical methods
All statistical analysis was conducted using Stata SE v10, Stat-
Corp, College Station, TX, USA andMatlab R2009b, TheMathWorks,
Natick, MA, USA.
Outcome variables
Analyses are restricted to patients receiving primary THR. If
a patient had the procedure on both sides (n¼ 95 out of 799), we
included the earliest operation, and bilateral operations were
excluded. Outcomes of interest are the OHS at 12 and 24-month
follow-up, and the difference between baseline and follow-upscores. However, these are continuous outcome variables, and
instead we wish to create binary outcomes, by identifying the cut-
off point on the OHS that relates to patient satisfaction. The clinical
anchor for this analysis was whether or not the patient was satis-
ﬁed with surgery. Hence, we aimed to identify the cut-point on the
follow-up OHS, and change in OHS, that relates to patient satis-
faction with surgery.
Two different statistical methods were used to identify cut-
points for patient satisfaction. First, a receiver operating charac-
teristic (ROC) curve analysis was used, where the gold standard is
whether or not a patient improved according to the anchoring
question, and we identify the cut-point on the follow-up OHS and
change in OHS that maximises sensitivity and speciﬁcity. We vali-
dated the ROC results with a further statistical approach, the 75th
percentile approach11, which identiﬁes the cut-off point corre-
sponding to the 75th percentile of the follow-up OHS and change in
OHS in patients answering yes to the anchoring question (satisﬁed
with surgery).
Exposure/stratiﬁcation variables
The methods described above to identify cut-points for the OHS,
were then repeated stratifying by the following variables: age (ter-
tiles), gender, BMI (tertiles), baseline OHS (tertiles), pre-operative
expectations of pain (not at all painful vs any pain), and expectations
of function (not limited at all vs any limitation) (see Table II).
Results
The cohort consisted of 799 patients at baseline, of whom 619
(77.5%) completed the 12-month follow-up questionnaire and 639
(80.0%) completed the 24-month questionnaire. Figure 1 shows the
participants at baseline, 12 months and 24 months. Table I compares
the clinical characteristics of all the patients at baseline with those
that also attended the 24-month follow-up. We can see that the two
groups were similar with no signiﬁcant differences in the important
patients’ characteristics. Data on the underlying diagnosis was
available on 239 patients only and revealed that 95.4% (228/239) had
received their hip operation because of osteoarthritis/coxarthrosis.
The remaining 4.6% (11/239) had THR due to avascular necrosis
(1.67%), failed post fracture ﬁxation (1.26%), acetabular erosion
secondary to hemiarthroplasty (0.42%), unspeciﬁed arthritis (0.42%),
hip dysplasia (0.42%) and joint pain (0.42%).
At 12months 91.9% (n¼ 564/614) of patients were satisﬁed with
their operation, with 92.8% (n¼ 582/627) at 24 months. Of the 45
patients who were not satisﬁed with their operation at 24 months,
Table I
Baseline clinical characteristics of the patients
Full cohort (n¼ 799) Non-respondents at
12-month follow-up
(n¼ 180)
Respondents at
12-month follow-up
(n¼ 619)
Non-respondents
at 24-month follow-up
(n¼ 160)
Respondents at
24-month follow-up
(n¼ 639)
Age
All, median (IQR) 68 (58,76) (n¼ 797) 65 (54,74) (n¼ 179) 68 (59,76) (n¼ 618)* 67.5 (56,77) (n¼ 158) 68 (59,75) (n¼ 639)
Low tertile, median [range] 54 [20,62] (n¼ 269) 51 [20,60] (n¼ 65) 55 [27,63] (n¼ 213)*** 53 [20,60] (n¼ 54) 55 [25,63] (n¼ 230)**
Medium tertile, median [range] 68 [63,73] (n¼ 275) 65 [63,71] (n¼ 56) 69 [64,73] (n¼ 204)*** 68 [61,74] (n¼ 52) 68 [64,73] (n¼ 216)
High tertile, median [range] 79 [74,100] (n¼ 253) 78.5 [72,100] (n¼ 58) 79 [74,93] (n¼ 201) 80 [75,100] (n¼ 52) 79 [74,93] (n¼ 193)
Gender
Female, frequency (%) 480 (60.1%) 107 (59.4%) 373 (60.3%) 96 (60.0%) 384 (60.1%)
Male, frequency (%) 319 (39.9%) 73 (40.6%) 246 (39.7%) 64 (40.0%) 255 (39.9%)
BMI
All, median (IQR) 27 (24,30) (n¼ 487) 27 (24,30) (n¼ 106) 27 (24,30) (n¼ 381) 27 (23,30) (n¼ 93) 27 (24,30) (n¼ 394)
Low tertile, median [range] 23 [15,25] (n¼ 197) 23 [15,25] (n¼ 42) 23 [17,25] (n¼ 155) 22 [15,24] (n¼ 32) 24 [17,25] (n¼ 155)**
Medium tertile, median [range] 27 [26,29] (n¼ 143) 27 [26,29] (n¼ 33) 27 [26,29] (n¼ 110) 27 [25,29] (n¼ 34) 27 [26,29] (n¼ 119)
High tertile, median [range] 32 [30,43] (n¼ 147) 33 [30,42] (n¼ 31) 32 [30,43] (n¼ 116) 33 [30,39] (n¼ 27) 32 [30,43] (n¼ 120)
OHS
All, median (IQR) 17 (11,23) (n¼ 799) 17 (12,24) (n¼ 180) 17 (11,23) (n¼ 619) 17 (12,23) (n¼ 160) 17 (11,23) (n¼ 639)
Low tertile, median [range] 9 [0,13] (n¼ 278) 10 [1,15] (n¼ 71) 9.5 [0,13] (n¼ 228)* 10 [1,14] (n¼ 57) 9 [0,13] (n¼ 230)
Medium tertile, median [range] 17 [14,21] (n¼ 277) 18 [16,21] (n¼ 51) 17 [14, 21] (n¼ 205) 17 [15,20] (n¼ 50) 17 [14,21] (n¼ 212)
High tertile, median [range] 27 [22,41] (n¼ 244) 26.5 [24,30] (n¼ 58) 27 [22,41] (n¼ 186) 25 [21,36] (n¼ 53) 27 [22,40] (n¼ 197)*
Duration of pain, median (IQR) 1e3 years
(1e3 years, 3e5 years)
(n¼ 630)
1e3 years
(1e3 years, 3e5 years)
(n¼ 83)
1e3 years
(1e3 years, 3e5 years)
(n¼ 547)
No observations 1e3 years
(1e3 years, 3e5 years)
(n¼ 630)
*p< 0.05, **p< 0.01, ***p< 0.00005.
Selection bias determined at each follow-up year by comparing non-respondents with respondents; for normally distributed data the independent 2 tail t-test was used; for
non-normally distributed data the Wilcoxon rank sum test was used; chi-square test used for categorical data.
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was 27(17,35) and 23(17,29) respectively. 52.5% had reported
a decrease in pain and 35.6% an increase in function (20% reported
both). Table II presents the proportions of patients satisﬁed withTable II
Proportion of patients satisﬁed with surgery and their OHS, stratiﬁed by baseline clinica
Satisfaction
12 months 24 months
Number (%) Number (%)
Age groups (tertiles)
Low 195 (91.98%) 211 (92.95%)
Medium 189 (92.65%) 197 (94.26%)
High 179 (90.86%) 174 (91.10%)
p-value 0.805 0.472
Gender
Female 340 (92.14%) 344 (91.98%)
Male 224 (91.43%) 238 (94.07%)
p-value 0.752 0.319
BMI (tertiles)
Low 144 (93.51%) 142 (93.42%)
Medium 97 (88.18%) 105 (89.74%)
High 109 (93.97%) 109 (92.37%)
p-value 0.192 0.536
Baseline OHS (tertiles)
Low 210 (92.51%) 209 (92.48%)
Medium 186 (91.63%) 194 (91.94%)
High 168 (91.30%) 179 (94.21%)
p-value 0.896 0.659
Pre-operative expectations - pain
Not at all painful 384 (90.78%) 394 (92.71%)
Any pain 175 (94.09%) 184 (92.9%)
Chi square test, p-value 0.171 0.960
Pre-operative expectations - function
Not limited at all 292 (93.29%) 284 (92.51%)
Any limitation 268 (90.24%) 294 (93.04%)
p-value 0.169 0.877
For non-normally distributed continuous data the KruskaleWallis rank sum test was usesurgery at each follow-up, broken down by baseline clinical char-
acteristics. Using chi-square tests of association there was no
evidence that baseline characteristics were associated with satis-
faction scores. A chi square test for trend was also used to comparel characteristics (tertile range as deﬁned in Table I)
Baseline OHS
12 months 24 months
Median (IQR) Median (IQR)
18 (13,24), n¼ 213 18 (13,24), n¼ 230
16 (11,22.5), n¼ 204 16.5 (10.5,23), n¼ 216
15 (10,22), n¼ 201 15 (10,22), n¼ 193
0.0146* 0.0308*
15 (10,22), n¼ 373 15.5 (10,22), n¼ 384
18 (12,24), n¼ 246 19 (13,25), n¼ 255
0.0003** 0.0001**
18 (12,24), n¼ 156 18 (12,24), n¼ 155
17 (11,25), n¼ 110 17 (11,25), n¼ 119
14 (10,20), n¼ 116 15 (10,20), n¼ 120
0.0017** 0.0127*
9.5 (7,12), n¼ 228 9 (11,7), n¼ 230
17 (16,20), n¼ 205 17 (16,20), n¼ 212
27 (24,30), n¼ 186 27 (24,30), n¼ 197
0.0001** 0.0001**
17 (11,23), n¼ 428 17 (11,23), n¼ 434
17 (11,23), n¼ 186 18 (11,23), n¼ 201
0.7001 0.8277
18 (12,24), n¼ 318 18 (11,24), n¼ 314
16 (10,22), n¼ 297 16 (10,22), n¼ 321
0.0132* 0.0028**
d; the chi-square test used for categorical data. *p< 0.05, **p< 0.01, ***p< 0.00005.
Table III
Outcomes at 12 and 24 months post-operation
12 months (n¼ 619) 24 months (n¼ 639)
Baseline OHS, median (IQR) 17 (11,23) 17 (11,23)
Follow-up OHS, median (IQR) 43 (36,47) 44 (38,47)
Change in OHS from baseline,
median (IQR)
24 (16,30) 24 (17,31)
PoPI, median (IQR) 83.3% (60.6%, 96.0%) 86.3% (65.6%, 97.1%)
Satisﬁed, (%) 91.9% (564/614) 92.8% (582/627)
Improved function, (%) 89.3% (550/616) 90.7% (572/631)
Reduced pain, (%) 94.3% (541/574) 92.7% (549/592)
Less medication, (%) 87.7% (515/587) 89.0% (544/611)
Improved since last visit, (%) 76.0% (562/608) 51.9% (329/634)
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year 1 as the binary outcome and tertiles of operation dates as the
ordered categorical exposure. This was repeated using satisfaction
responses at year 2. The results at each year of follow-up were non-
signiﬁcant (year 1, p¼ 0.215; year 2, p¼ 0.488), suggesting there
was no linear trend present in the satisfaction responses of patients
over time.
The changes in OHS from baseline to 12 months and 24 months
and PoPI are shown in Table III. The median improvement in OHS
was 24 at 12 months and 24 months. The percentage of patients
reporting an improvement since their previous visit was 76.0% at 12
months, but this fell to 51.9% between 12 and 24 months.Fig. 2. ROC and 75th centile plots for satisfaction at 24 months. The 75th centile method cu
our analysis, as ‘0’ represents a poor result and ‘48’ represents a good result, the 75th percen
other authors may have their scoring system in reverse, where ‘48’ is a poor result and ‘0’The OHS at 12 months associated with patient satisfaction was
38 using the ROC curve technique (38 using the 75th centile
approach). For the 24-month OHS the cut-point was 33 (ROC) and 40
(75th centile). Plots for both methods at 24 months can be seen in
Fig. 2. The sensitivity and speciﬁcity of the ROC technique at 24
months are 89.7% and 86.7% respectively. The changes in OHS asso-
ciatedwith satisfaction using the ROCwere 15 at 12months and 14 at
24 months.
Figure 3 displays the cut-points for the follow-up OHS, the
change in OHS and PoPI, associated with satisfaction at 24 months
using the ROC method, stratiﬁed by important pre-operative clin-
ical variables. For the follow-up OHS (Fig. 3), there were little
differences for age or gender at the 24-month visit. Patients with
a high baseline OHS had higher follow-up OHS cut-points for
satisfaction. Patients with the lowest BMI had the highest OHS
threshold at 24 months (43, 32 and 34 respectively). Patients’ pre-
operative expectations had little impact on cut-points at 24
months.
The cut-points using change in OHS between baseline and 24
months (Fig. 3) demonstrated much greater variation between the
clinical strata than those using the 24-month OHS. The value
associated with satisfaction was higher in females than males and
there were large variations according to BMI and the patients’ pre-
operative expectations. Patients with the highest baseline OHS
required the lowest change in OHS to be satisﬁed. The PoPI have
less variation than the changes score, but more than the score at 24ts the ranked data such that positive responses are contained within 75% of the data. In
tile has been taken from the top end of the OHS, i.e., the cut point is at 25%. The work of
is a good result, in which case their cut point is at 75%.
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Fig. 3. ROC analysis: OHS based cut points using satisfaction as a binary classiﬁer with 95% CI, stratiﬁed by baseline clinical variables.
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age.
Discussion
Principal ﬁndings
The OHS is currently being used as a PROM instrument, in order
to assess whether hip replacement surgery has been successful
from the patients perspective in terms of self reported pain and
function. However the OHS is measured on a continuous scale from
0 (bad) to 48 (good), and it is unclear what cut point represents
a satisfactory outcome when assessing patients’ after surgery. For
the ﬁrst time, this study provides data on thresholds for the OHS
that relate to patient satisfaction with surgery in standard practice
in the NHS. Over 90% of patients are satisﬁed with their operation
from 12 months, with the vast majority remaining satisﬁed at 24
months. Furthermore, even though patients reported continued
improvement between 12 and 24 months, levels of satisfaction and
change in OHS remained stable. We have identiﬁed a value of the
OHS and change in OHS, which predicts patient satisfaction at 12
and 24 months within a standard clinical setting. The clinical
application of this threshold is limited, however, as it varies
according to several important factors such as pre-operative OHS
and BMI and threshold stratiﬁed by these factors should be
adopted.
Strength and limitations
The strengths of this study include the relatively large cohort,
the use of a reliable, valid and responsive instrument for assessing
outcomes of hip replacement surgery6, data that has been collected
prospectively with a good rate of follow-up within a standard NHSsetting with multiple surgeons. While the beneﬁts of this study
were the comprehensive nature of its data collection and therefore
the validity of the results, the generalisability of this study is limited
as all subjects were recruited from one hospital. A repeat of this
study at other centres would provide a better representation of the
UK. As with most cohort studies, this study is subject to an
incomplete follow-up of patients. Our response rates however were
acceptable at between 77 and 80% and we found no evidence that
non-responders differed from responders in important variables
and hence are conﬁdent that this will not have signiﬁcantly affected
our results.
In order to estimate the OHS score for satisfaction at follow-up,
we used a single anchoring question on patient satisfaction with
the outcome of surgery. This is a similar concept to the widely used
Patient Acceptable Symptom State (PASS)9e11. This is not a true
PASS, as our anchoring question enquires about satisfactionwith an
operation that will include aspects of the patients current symp-
toms, but also their prior level of symptoms in addition to their
response and expectations of surgery. Whilst a Likert scale
response to satisfaction would have provided more detail in the
analysis, the binary response used in the OHS questionnaire was
sufﬁcient (and required) for ROC curve analysis. It has also been
suggested that rather than using one global anchor question,
separate anchors should be used for each domain (pain and func-
tion) of the outcome measure. In addition other outcomes such as
hospital facilities, infection rates and peri-operative mortality are
not captured by the OHS and are important measures that inform
patient choice.
What is already known?
In this study over 90% of patients reported they were satisﬁed
with the outcome of THR surgery at each follow-up. A large
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the UK found that 89% of patients were satisﬁed with the operation
at 1-year follow-up8. Data from the NJR found that 89.8% of patients
were satisﬁed at least 1 year after the surgery12. Long term follow-
up of the Trent regional arthroplasty register suggests satisfaction
rates of 94.1% at 5 years13 and 96.9% at 10 years4. The study by
Nilsdotter et al. of patients receiving primary THR for OA in Sweden
found satisfaction rates of 96% at 3.6 years14, but as the authors
highlight, even if the patient reports a bad outcome in pain and
function they may still be satisﬁed with surgery, and satisfaction is
a wide concept, not necessarily relevant in outcome after THR. This
is why we have attempted to ﬁnd a threshold for follow-up and
change in OHS (a valid, responsive instrument to assess THR
outcomes) in patients that are satisﬁed with surgery, rather than
looking at satisfaction alone.
Other studies in the literature also suggest that there are an
important minority of patients that have poor outcomes of THR in
terms of change in pain and function. MacWilliam et al. found that
approximately 16% of patients report no change or increased pain at
6 months, and 24% of patients report no change or decreased
physical function at 6 months15. Nilsdotter et al. found between 9
and 25% of patients did not respond to treatment dependant on the
way patients were classiﬁed as non-responders to surgery14. In line
with other studies, their results also show that at follow-up,
patients still had worse pain and function scores16,17 than ageesex
matched controls not receiving THR, suggesting that patients do
not return to the same levels of pain and function as those in the
general population. Quintana et al. demonstrated that at 6-month
posts surgery, 70% of patients were classiﬁed as responders in
terms of pain and function16. Whilst others have published values
for the MCID based on WOMAC scores and VAS scales11,16, to our
knowledge, no other studies have provided cut-points for the OHS
that relates to patient satisfaction, and such information has been
requested in order to determine the real clinical or subjective
meaning in changes in OHS6.
What does this study add?
Increasing attention has been focused on the use of patient-
reported outcome measures (PROMS) and assessments of satis-
faction in evaluating THR surgery18. In the United Kingdom, there
is now a national requirement to report PROMS on all patients
undergoing THR’s19 using a condition-speciﬁc instrument OHS,
a generic instrument (EQ5D) and general patient-speciﬁc infor-
mation20. The idea behind these PROMS instruments is to measure
whether surgery has worked by seeing if the patient “feels” better.
By publishing such data the idea is to improve the quality of care
received. These data will feed into the patient choice agenda as
patients will be able to access such information when making
a decision about surgery. The idea behind giving patients choice, is
that it allows them to make an informed decision about their
treatment with their general practitioner (GP), that best meets
their needs. This feeds into the idea of using informed decision-
making (IDM) in patienteGP communication. With shared deci-
sion making the onus is on the GP to ensure that patients have all
the information they need, that they understand their treatment
options, and then help them to make an informed decision that
corresponds with their preferences21.
However, the OHS is a continuous outcome measure, and to
know that having hip surgery will change your score by ‘x’ points is
not informative to either patients or clinicians. Instead it is pref-
erable to categorize patients into those who do or do not improve
after surgery, so that as part of patienteclinician decision-making,
a patient will know the likely improvement in pain and function
they can expect as a percentage. Part of the PROMS agenda is topublish this data, and it is necessary to know what cut-point
represents a clinically acceptable outcome of surgery, so we can
estimate the proportion of patients that have responded to surgery
in each hospital.
The results of this study provide a value of 38 on the 12-month
OHS (33 at 24 months) that relates to patient satisfaction with
surgery in standard practice in the NHS. This data will increase the
usefulness of the OHS as a PROM instrument and make the data
more meaningful to both patients and clinicians. We would
however, caution against the use of a single set cut-point for the
OHS as our analyses suggested that patients with lower baseline
OHS (worse pre-operative pain and function) and those with
higher BMI had lower values for OHS cut-points, suggesting that
such patient groups are more likely to be satisﬁed with the
outcomes of surgery with smaller improvements in pain and
function. We should therefore recommend using different set
points based on speciﬁc pre-operative patient characteristics.
These data provide the ﬁrst published information on how to use
the OHS for assessing patient satisfaction post surgery for use in
clinical settings, however, validation in other cohorts is ideally
required before their widespread implementation. The alternative
approach of using change in OHS as an outcome, did not perform
well in these analyses as it leads to more heterogeneity amongst
strata.Unanswered questions and future research
THR surgery is one of the best surgical interventions making
a substantial contribution to public health. It is one of the most
common elective surgical procedures, shown to be a cost effec-
tive, with good prosthesis survival rates, reducing pain,
increasing mobility and improving quality of life22e25. Increasing
attention is focused on the use of PROMS and assessments of
satisfaction in evaluating THR surgery, with the OHS being the
condition speciﬁc PROM of choice. This study has identiﬁed
a threshold for follow-up OHS at 12 and 24 months that relates to
a clinically important improvement related to patient satisfac-
tion with surgery, with good sensitivity and speciﬁcity. Further
research is required to validate these cut points for speciﬁc
patient sub groups in other cohorts and to deﬁne the cut-points
at 6-month post-operation.Author contributions
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Appendix
Results from the ROC analysis at 24 months; sensitivity, speciﬁcity, area under the curve (AUC) with 95% conﬁdence interval (CI) and corresponding OHS related
cut-point
n Sensitivity Speciﬁcity AUC Cut point
OHS at 24 months
All 627 0.897 (0.869, 0.920) 0.867 (0.732, 0.949) 0.934 (0.902, 0.967) 33
Female 374 0.933 (0.901, 0.957) 0.800 (0.614, 0.923) 0.919 (0.869, 0.968) 30
Male 253 0.916 (0.873, 0.948) 0.933 (0.681, 0.998) 0.959 (0.931, 0.987) 33
Age tertile - low 227 0.938 (0.897, 0.967) 0.813 (0.544, 0.960) 0.937 (0.888, 0.986) 33
Age tertile - medium 209 0.898 (0.848, 0.937) 0.917 (0.615, 0.998) 0.931 (0.859, 1.000) 33
Age tertile - high 191 0.845 (0.782, 0.895) 0.882 (0.636, 0.985) 0.936 (0.887, 0.984) 33
BMI tertile - low 152 0.732 (0.652, 0.803) 1.000 (0.692, 1.000) 0.895 (0.822, 0.967) 43
BMI tertile - medium 117 0.981 (0.933, 0.998) 0.917 (0.615, 0.998) 0.980 (0.949, 1.000) 27
BMI tertile - high 118 0.908 (0.838, 0.955) 1.000 (0.664, 1.000) 0.966 (0.934, 0.997) 34
Baseline OHS tertile - low 226 0.871 (0.818, 0.913) 0.941 (0.713, 0.999) 0.947 (0.915, 0.980) 30
Baseline OHS tertile - medium 211 0.933 (0.888, 0.964) 0.941 (0.713, 0.999) 0.975 (0.941, 1.000) 33
Baseline OHS tertile - high 190 0.726 (0.655, 0.790) 0.909 (0.587, 0.998) 0.898 (0.819, 0.977) 43
Expectations: no pain 425 0.909 (0.876, 0.935) 0.871 (0.702, 0.964) 0.942 (0.906, 0.979) 33
Expectations: some pain 189 0.880 (0.822, 0.924) 0.857 (0.572, 0.982) 0.909 (0.838, 0.981) 32
Expectations: no limitation 307 0.940 (0.906, 0.965) 0.826 (0.612, 0.950) 0.940 (0.901, 0.980) 33
Expectations: some limitation 307 0.849 (0.802, 0.889) 0.909 (0.708, 0.989) 0.936 (0.883, 0.989) 33
Change in OHS
All 627 0.881 (0.852, 0.907) 0.778 (0.629, 0.888) 0.920 (0.884, 0.955) 14
Female 374 0.834 (0.791, 0.872) 0.800 (0.614, 0.923) 0.909 (0.863, 0.954) 16
Male 253 0.962 (0.929, 0.983) 0.800 (0.519, 0.957) 0.953 (0.911, 0.995) 8
Age tertile - low 227 0.967 (0.933, 0.987) 0.688 (0.413, 0.890) 0.904 (0.829, 0.979) 9
Age tertile - medium 209 0.670 (0.600, 0.735) 1.000 (0.735, 1.000) 0.886 (0.823, 0.949) 21
Age tertile - high 191 0.908 (0.855, 0.947) 0.941 (0.713, 0.999) 0.956 (0.913, 0.999) 13
BMI tertile - low 152 0.880 (0.815, 0.929) 0.900 (0.555, 0.997) 0.926 (0.851, 1.000) 14
BMI tertile - medium 117 0.962 (0.905, 0.990) 0.833 (0.516, 0.979) 0.936 (0.868, 1.000) 10
BMI tertile - high 118 0.706 (0.612, 0.790) 1.000 (0.664, 1.000) 0.899 (0.812, 0.985) 23
Baseline OHS tertile - low 226 0.842 (0.785, 0.889) 1.000 (0.805, 1.000) 0.946 (0.912, 0.979) 23
Baseline OHS tertile - medium 211 0.923 (0.876, 0.956) 0.941 (0.713, 0.999) 0.974 (0.944, 1.000) 17
Baseline OHS tertile - high 190 0.888 (0.833, 0.930) 0.909 (0.587, 0.998) 0.913 (0.816, 1.000) 9
Expectations: no pain 425 0.888 (0.853, 0.918) 0.839 (0.663, 0.945) 0.934 (0.894, 0.974) 14
Expectations: some pain 189 0.646 (0.570, 0.716) 1.000 (0.768, 1.000) 0.894 (0.823, 0.964) 22
Expectations: no limitation 307 0.887 (0.845, 0.922) 0.783 (0.563, 0.925) 0.916 (0.865, 0.967) 14
Expectations: some limitation 307 0.916 (0.877, 0.945) 0.773 (0.546, 0.922) 0.926 (0.877, 0.974) 12
PoPI
All 627 0.864 (0.834, 0.891) 0.956 (0.849, 0.995) 0.954 (0.929, 0.978) 58%
Female 374 0.860 (0.819, 0.895) 0.933 (0.779, 0.992) 0.940 (0.904, 0.976) 58%
Male 253 0.912 (0.868, 0.945) 1.000 (0.782, 1.000) 0.978 (0.960, 0.996) 51%
Age tertile - low 227 0.910 (0.863, 0.945) 0.938 (0.698, 0.998) 0.958 (0.920, 0.995) 58%
Age tertile - medium 209 0.893 (0.842, 0.933) 0.917 (0.615, 0.998) 0.933 (0.874, 0.991) 51%
Age tertile - high 191 0.874 (0.815, 0.919) 1.000 (0.805, 1.000) 0.970 (0.947, 0.994) 50%
BMI tertile - low 152 0.887 (0.823, 0.934) 0.900 (0.555, 0.997) 0.933 (0.875, 0.991) 55%
BMI tertile - medium 117 0.914 (0.844, 0.960) 1.000 (0.735, 1.000) 0.979 (0.955, 1.000) 51%
BMI tertile - high 118 0.853 (0.773, 0.914) 1.000 (0.664, 1.000) 0.960 (0.920, 1.000) 59%
Baseline OHS tertile - low 226 0.833 (0.775, 0.880) 1.000 (0.805, 1.000) 0.948 (0.915, 0.980) 58%
Baseline OHS tertile - medium 211 0.938 (0.894, 0.968) 0.941 (0.713, 0.999) 0.975 (0.943, 1.000) 52%
Baseline OHS tertile - high 190 0.883 (0.826, 0.926) 0.909 (0.587, 0.998) 0.927 (0.856, 0.999) 54%
Expectations: no pain 425 0.881 (0.845, 0.911) 0.968 (0.833, 0.999) 0.966 (0.941, 0.991) 58%
Expectations: some pain 189 0.857 (0.796, 0.905) 0.929 (0.661, 0.998) 0.923 (0.865, 0.982) 51%
Expectations: no limitation 307 0.919 (0.881, 0.948) 0.957 (0.781, 0.999) 0.963 (0.934, 0.991) 54%
Expectations: some limitation 307 0.888 (0.845, 0.922) 0.909 (0.708, 0.989) 0.946 (0.904, 0.988) 47%
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